Hostname: page-component-788cddb947-tr9hg Total loading time: 0 Render date: 2024-10-18T09:26:23.841Z Has data issue: false hasContentIssue false

Comparison of Medicare Claims-based Clostridioides difficile infection classification to chart review using a linked cohort

Published online by Cambridge University Press:  16 September 2024

Dustin Currie
Affiliation:
Centers for Disease Control and Prevention
Chantal Lewis
Affiliation:
Centers for Disease Control and Prevention
Kelly Hatfield
Affiliation:
Centers for Disease Control and Prevention
Joseph Lutgring
Affiliation:
Centers for Disease Control and Prevention
Sophia Kazakova
Affiliation:
Centers for Disease Control and Prevention
James Baggs
Affiliation:
Centers for Disease Control and Prevention
Lauren Korhonen
Affiliation:
Centers for Disease Control and Prevention
Maria Correa
Affiliation:
Connecticut Emerging Infections Program
Dana Goodenough
Affiliation:
Georgia Emerging Infections Program/Foundation for Atlanta Veterans Education and Research/Atlanta VA Medical Center
Danyel Olson
Affiliation:
Connecticut Emerging Infections Program, Yale School of Public Health
Jill Szydlowski
Affiliation:
University of Rochester Medical Center
Jasmine Watkins
Affiliation:
Tennessee Department of Health
Ghinwa Dumyati
Affiliation:
University of Rochester Medical Center
Scott Fridkin
Affiliation:
Emory Healthcare and Emory University
Christopher Wilson
Affiliation:
Tennessee Department of Health
Sujan Reddy
Affiliation:
Centers for Disease Control and Prevention
Alice Guh
Affiliation:
Centers for Disease Control and Prevention

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Background: Medicare claims are frequently used to study Clostridioides difficile infection (CDI) epidemiology. Categorizing CDI based on location of onset and potential exposure is critical in understanding transmission patterns and prevention strategies. While claims data are well-suited for identifying prior healthcare utilization exposures, they lack specimen collection and diagnosis dates to assign likely location of onset. Algorithms to classify CDI onset and healthcare association using claims data have been published, but the degree of misclassification is unknown. Methods: We linked patients with laboratory-confirmed CDI reported to four Emerging Infections Program (EIP) sites from 2016-2020 to Medicare beneficiaries using residence, birth date, sex, and hospitalization and/or healthcare exposure dates. Uniquely linked patients with fee-for-service Medicare A/B coverage and complete EIP case report forms were included. Patients with a claims CDI diagnosis code within ±28 days of a positive CDI test reported to EIP were categorized as hospital-onset (HO), long-term care facility onset (LTCFO), or community-onset (CO, either healthcare facility-associated [COHCFA] or community-associated [CA]) using a previously published algorithm based on claim type, ICD-10-CM code position, and duration of hospitalization (if applicable). EIP classifies CDI into these categories using positive specimen collection date and other information from chart review (e.g. admit/discharge dates). We assessed concordance of EIP and claims case classifications using Cohen’s kappa. Results: Of 10,002 eligible EIP-identified CDI cases, 7,064 were linked to a unique beneficiary; 3,451 met Medicare A/B fee-for-service coverage inclusion criteria. Of these, 650 (19%) did not have a claims diagnosis code ±28 days of the EIP specimen collection date (Table); 48% (313/650) of those without a claims diagnosis code were categorized by EIP as CA CDI. Among those with a CDI diagnosis code, concurrence of claims-based and EIP CDI classification was 68% (κ=0.56). Concurrence was highest for HO and lowest for COHCFA CDI. A substantial number of EIP-classified CO CDIs (30%, Figure) were misclassified as HO using the claims-based algorithm; half of these had a primary ICD-10 diagnosis code of sepsis (226/454; 50%). Conclusions: Evidence of CDI in claims data was found for 81% of EIP-reported CDI cases. Medicare classification algorithms concurred with the EIP classification in 68% of cases. Discordance was most common for community-onset CDI patients, many of whom were hospitalized with a primary diagnosis of sepsis. Misclassification of CO-CDI as HO may bias findings of claims-based CDI studies.

Type
C. difficile
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America